Publication | Closed Access

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

Radiation MedicineAdvanced Head-and-neck CancerRadiation TherapyMedicineSimultaneous Chemotherapy—resultsHead And Neck CancerAccelerated RadiotherapyNeck OncologyOncologyRadiation OncologyRadiologyHealth Sciences